<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250709066430N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-08-05</date_registration>
      <primary_sponsor>Azad University, South Tehran Branch</primary_sponsor>
      <public_title>The effectiveness of schema therapy on self-compassion and cognitive distortion of adolescents</public_title>
      <acronym></acronym>
      <scientific_title>The effectiveness of schema therapy on self-compassion and cognitive distortion of adolescents affected by emotional failure</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-09-03</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/85295</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: Experimental and control groups: After selecting the sample, the next step involves dividing people into experimental and control groups using a random method.
How to perform randomization: First step: After selecting the voluntary sample, all selected people are placed on a list (numbers from 1 to 30 are assigned to people). Second step: From these people, using a random method using sealed and opaque (numbered) envelopes, people are divided into two experimental groups and a control group. Each person randomly selects an envelope and is divided into the corresponding group, Blinding description: The study was conducted in a double-blind manner; participants, caregivers, and evaluators were unaware of group assignment, and a unique code was assigned to each individual.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Emotional failure.</hc_freetext>
      <i_freetext>Intervention 1: Control group: 15 participants who meet the inclusion criteria and do not have disorders such as depression or anxiety diagnosed by a therapist will be randomly assigned to the study as the control group. They will complete the self-compassion and cognitive distortion questionnaire, but no treatment will be given to this group. Intervention 2: Intervention group: 15 participants in the study who meet the inclusion criteria and do not have disorders such as depression and anxiety diagnosed by the therapist will be randomly assigned to the intervention group. They will complete the self-compassion and cognitive distortion questionnaire as a pre-test, then undergo 10 sessions of schema therapy based on Yang (2003), each session lasting 90 minutes, and after completing the sessions, they will complete the self-compassion and cognitive distortion questionnaires as a post-test.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Demographic data and the main outcome results of the research can be shared after de-identification and preserving the privacy of individuals.

When:
Data can be made available 4 months after the results are published and after personally identifiable information is removed.

To whom:
The study data and documentation will be available to researchers and scholars working at reputable academic and scientific institutions.

Conditions:
Research data and documentation may be used for scientific and research purposes. Users must undertake to keep non-identifiable data confidential.

Where to obtain:
If you need data, please contactmohamad78.nabie19@gmail.com

How to obtain:
After receiving and reviewing the request from the researcher, a response will be provided as soon as possible.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammad Nabaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Unit 5, No. 155, Yas 7 Alley, Pasgah Street, Hashtgerd, Alborz, Iran</address>
        <city>Hashtgerd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۳۳۶۱۶۷۳۷۷۸</zip>
        <telephone>+98 26 4423 2684</telephone>
        <email>mohamad78.nabie19@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hosein Tavakoli</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Valiasr Complex, South Tehran Branch, Islamic Azad University, Damavand Street, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1734643905</zip>
        <telephone>+98 21 7746 2251</telephone>
        <email>Rinotavakoli55@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Male teenagers who have been injured due to emotional failure during the last 3 months.
Age range between 15-18 years
Adolescents who score high on the Ross Love Impact Questionnaire (1999)</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>18 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Adolescents with disorders such as depression and anxiety</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F99</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Mental disorder, not otherwise specified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: 15 participants who meet the inclusion criteria and do not have disorders such as depression or anxiety diagnosed by a therapist will be randomly assigned to the study as the control group. They will complete the self-compassion and cognitive distortion questionnaire, but no treatment will be given to this group.</i_keyword>
      <i_keyword>Intervention group: 15 participants in the study who meet the inclusion criteria and do not have disorders such as depression and anxiety diagnosed by the therapist will be randomly assigned to the intervention group. They will complete the self-compassion and cognitive distortion questionnaire as a pre-test, then undergo 10 sessions of schema therapy based on Yang (2003), each session lasting 90 minutes, and after completing the sessions, they will complete the self-compassion and cognitive distortion questionnaires as a post-test.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Self -Compassion. Timepoint: It will be assessed before and after the intervention. Method of measurement: Self-Compassion Questionnaire (Neff, 2003).</prim_outcome>
      <prim_outcome>Cognitive Distortion. Timepoint: Before the intervention and after the intervention. Method of measurement: Abdollahzadeh and Salar Cognitive Distortion Questionnaire 2010.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Azad University, South Tehran Branch</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-06-10</approval_date>
        <contact_name>Research Ethics Committees of Islamic Azad University -Varamin- Pishva Branchn</contact_name>
        <contact_address>Islamic Azad University, Varamin–Pishva Branch, Naghsh-e Jahan Town, Pishva County, Tehran, Iran Varamin Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
